Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis

Phuoc T. Tran, Emelyn H. Shroff, Timothy F. Burns, Saravanan Thiyagarajan, Sandhya T. Das, Tahera Zabuawala, Joy Chen, Yoon-Jae Cho, Richard Luong, Pablo Tamayo, Tarek Salih, Khaled Aziz, Stacey J. Adam, Silvestre Vicent, Carsten H. Nielsen, Nadia Withofs, Alejandro Sweet-Cordero, Sanjiv S. Gambhir, Charles M. Rudin, Dean W. Felsher

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

KRAS mutant lung cancers are generally refractory to chemotherapy as well targeted agents. To date, the identification of drugs to therapeutically inhibit K-RAS have been unsuccessful, suggesting that other approaches are required. We demonstrate in both a novel transgenic mutant Kras lung cancer mouse model and in human lung tumors that the inhibition of Twist1 restores a senescence program inducing the loss of a neoplastic phenotype. The Twist1 gene encodes for a transcription factor that is essential during embryogenesis. Twist1 has been suggested to play an important role during tumor progression. However, there is no in vivo evidence that Twist1 plays a role in autochthonous tumorigenesis. Through two novel transgenic mouse models, we show that Twist1 cooperates with KrasG12D to markedly accelerate lung tumorigenesis by abrogating cellular senescence programs and promoting the progression from benign adenomas to adenocarcinomas. Moreover, the suppression of Twist1 to physiological levels is sufficient to cause Kras mutant lung tumors to undergo senescence and lose their neoplastic features. Finally, we analyzed more than 500 human tumors to demonstrate that TWIST1 is frequently overexpressed in primary human lung tumors. The suppression of TWIST1 in human lung cancer cells also induced cellular senescence. Hence, TWIST1 is a critical regulator of cellular senescence programs, and the suppression of TWIST1 in human tumors may be an effective example of pro-senescence therapy.

Original languageEnglish (US)
Article numbere1002650
JournalPLoS genetics
Volume8
Issue number5
DOIs
StatePublished - May 1 2012
Externally publishedYes

Fingerprint

lung neoplasms
senescence
tumor
carcinogenesis
Carcinogenesis
lungs
Lung
mutants
Cell Aging
cancer
Lung Neoplasms
Neoplasms
neoplasms
animal models
genetically modified organisms
chemotherapy
adenoma
adenocarcinoma
Adenoma
Transgenic Mice

ASJC Scopus subject areas

  • Ecology, Evolution, Behavior and Systematics
  • Molecular Biology
  • Genetics
  • Genetics(clinical)
  • Cancer Research

Cite this

Tran, P. T., Shroff, E. H., Burns, T. F., Thiyagarajan, S., Das, S. T., Zabuawala, T., ... Felsher, D. W. (2012). Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis. PLoS genetics, 8(5), [e1002650]. https://doi.org/10.1371/journal.pgen.1002650

Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis. / Tran, Phuoc T.; Shroff, Emelyn H.; Burns, Timothy F.; Thiyagarajan, Saravanan; Das, Sandhya T.; Zabuawala, Tahera; Chen, Joy; Cho, Yoon-Jae; Luong, Richard; Tamayo, Pablo; Salih, Tarek; Aziz, Khaled; Adam, Stacey J.; Vicent, Silvestre; Nielsen, Carsten H.; Withofs, Nadia; Sweet-Cordero, Alejandro; Gambhir, Sanjiv S.; Rudin, Charles M.; Felsher, Dean W.

In: PLoS genetics, Vol. 8, No. 5, e1002650, 01.05.2012.

Research output: Contribution to journalArticle

Tran, PT, Shroff, EH, Burns, TF, Thiyagarajan, S, Das, ST, Zabuawala, T, Chen, J, Cho, Y-J, Luong, R, Tamayo, P, Salih, T, Aziz, K, Adam, SJ, Vicent, S, Nielsen, CH, Withofs, N, Sweet-Cordero, A, Gambhir, SS, Rudin, CM & Felsher, DW 2012, 'Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis', PLoS genetics, vol. 8, no. 5, e1002650. https://doi.org/10.1371/journal.pgen.1002650
Tran, Phuoc T. ; Shroff, Emelyn H. ; Burns, Timothy F. ; Thiyagarajan, Saravanan ; Das, Sandhya T. ; Zabuawala, Tahera ; Chen, Joy ; Cho, Yoon-Jae ; Luong, Richard ; Tamayo, Pablo ; Salih, Tarek ; Aziz, Khaled ; Adam, Stacey J. ; Vicent, Silvestre ; Nielsen, Carsten H. ; Withofs, Nadia ; Sweet-Cordero, Alejandro ; Gambhir, Sanjiv S. ; Rudin, Charles M. ; Felsher, Dean W. / Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis. In: PLoS genetics. 2012 ; Vol. 8, No. 5.
@article{efe953f3fa46439e84aa79a581484d9b,
title = "Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis",
abstract = "KRAS mutant lung cancers are generally refractory to chemotherapy as well targeted agents. To date, the identification of drugs to therapeutically inhibit K-RAS have been unsuccessful, suggesting that other approaches are required. We demonstrate in both a novel transgenic mutant Kras lung cancer mouse model and in human lung tumors that the inhibition of Twist1 restores a senescence program inducing the loss of a neoplastic phenotype. The Twist1 gene encodes for a transcription factor that is essential during embryogenesis. Twist1 has been suggested to play an important role during tumor progression. However, there is no in vivo evidence that Twist1 plays a role in autochthonous tumorigenesis. Through two novel transgenic mouse models, we show that Twist1 cooperates with KrasG12D to markedly accelerate lung tumorigenesis by abrogating cellular senescence programs and promoting the progression from benign adenomas to adenocarcinomas. Moreover, the suppression of Twist1 to physiological levels is sufficient to cause Kras mutant lung tumors to undergo senescence and lose their neoplastic features. Finally, we analyzed more than 500 human tumors to demonstrate that TWIST1 is frequently overexpressed in primary human lung tumors. The suppression of TWIST1 in human lung cancer cells also induced cellular senescence. Hence, TWIST1 is a critical regulator of cellular senescence programs, and the suppression of TWIST1 in human tumors may be an effective example of pro-senescence therapy.",
author = "Tran, {Phuoc T.} and Shroff, {Emelyn H.} and Burns, {Timothy F.} and Saravanan Thiyagarajan and Das, {Sandhya T.} and Tahera Zabuawala and Joy Chen and Yoon-Jae Cho and Richard Luong and Pablo Tamayo and Tarek Salih and Khaled Aziz and Adam, {Stacey J.} and Silvestre Vicent and Nielsen, {Carsten H.} and Nadia Withofs and Alejandro Sweet-Cordero and Gambhir, {Sanjiv S.} and Rudin, {Charles M.} and Felsher, {Dean W.}",
year = "2012",
month = "5",
day = "1",
doi = "10.1371/journal.pgen.1002650",
language = "English (US)",
volume = "8",
journal = "PLoS Genetics",
issn = "1553-7390",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis

AU - Tran, Phuoc T.

AU - Shroff, Emelyn H.

AU - Burns, Timothy F.

AU - Thiyagarajan, Saravanan

AU - Das, Sandhya T.

AU - Zabuawala, Tahera

AU - Chen, Joy

AU - Cho, Yoon-Jae

AU - Luong, Richard

AU - Tamayo, Pablo

AU - Salih, Tarek

AU - Aziz, Khaled

AU - Adam, Stacey J.

AU - Vicent, Silvestre

AU - Nielsen, Carsten H.

AU - Withofs, Nadia

AU - Sweet-Cordero, Alejandro

AU - Gambhir, Sanjiv S.

AU - Rudin, Charles M.

AU - Felsher, Dean W.

PY - 2012/5/1

Y1 - 2012/5/1

N2 - KRAS mutant lung cancers are generally refractory to chemotherapy as well targeted agents. To date, the identification of drugs to therapeutically inhibit K-RAS have been unsuccessful, suggesting that other approaches are required. We demonstrate in both a novel transgenic mutant Kras lung cancer mouse model and in human lung tumors that the inhibition of Twist1 restores a senescence program inducing the loss of a neoplastic phenotype. The Twist1 gene encodes for a transcription factor that is essential during embryogenesis. Twist1 has been suggested to play an important role during tumor progression. However, there is no in vivo evidence that Twist1 plays a role in autochthonous tumorigenesis. Through two novel transgenic mouse models, we show that Twist1 cooperates with KrasG12D to markedly accelerate lung tumorigenesis by abrogating cellular senescence programs and promoting the progression from benign adenomas to adenocarcinomas. Moreover, the suppression of Twist1 to physiological levels is sufficient to cause Kras mutant lung tumors to undergo senescence and lose their neoplastic features. Finally, we analyzed more than 500 human tumors to demonstrate that TWIST1 is frequently overexpressed in primary human lung tumors. The suppression of TWIST1 in human lung cancer cells also induced cellular senescence. Hence, TWIST1 is a critical regulator of cellular senescence programs, and the suppression of TWIST1 in human tumors may be an effective example of pro-senescence therapy.

AB - KRAS mutant lung cancers are generally refractory to chemotherapy as well targeted agents. To date, the identification of drugs to therapeutically inhibit K-RAS have been unsuccessful, suggesting that other approaches are required. We demonstrate in both a novel transgenic mutant Kras lung cancer mouse model and in human lung tumors that the inhibition of Twist1 restores a senescence program inducing the loss of a neoplastic phenotype. The Twist1 gene encodes for a transcription factor that is essential during embryogenesis. Twist1 has been suggested to play an important role during tumor progression. However, there is no in vivo evidence that Twist1 plays a role in autochthonous tumorigenesis. Through two novel transgenic mouse models, we show that Twist1 cooperates with KrasG12D to markedly accelerate lung tumorigenesis by abrogating cellular senescence programs and promoting the progression from benign adenomas to adenocarcinomas. Moreover, the suppression of Twist1 to physiological levels is sufficient to cause Kras mutant lung tumors to undergo senescence and lose their neoplastic features. Finally, we analyzed more than 500 human tumors to demonstrate that TWIST1 is frequently overexpressed in primary human lung tumors. The suppression of TWIST1 in human lung cancer cells also induced cellular senescence. Hence, TWIST1 is a critical regulator of cellular senescence programs, and the suppression of TWIST1 in human tumors may be an effective example of pro-senescence therapy.

UR - http://www.scopus.com/inward/record.url?scp=84863651484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863651484&partnerID=8YFLogxK

U2 - 10.1371/journal.pgen.1002650

DO - 10.1371/journal.pgen.1002650

M3 - Article

VL - 8

JO - PLoS Genetics

JF - PLoS Genetics

SN - 1553-7390

IS - 5

M1 - e1002650

ER -